Drug Shortage Report for TARO-CIPROFLOXACIN/DEXAMETHASONE

Last updated on 2024-03-01 History
Report ID 150683
Drug Identification Number 02481901
Brand name TARO-CIPROFLOXACIN/DEXAMETHASONE
Common or Proper name CIPRO/DEXA
Company Name TARO PHARMACEUTICALS INC
Market Status MARKETED
Active Ingredient(s) DEXAMETHASONE CIPROFLOXACIN
Strength(s) 0.1% 0.3%
Dosage form(s) SUSPENSION
Route of administration OTIC
Packaging size 7.5
ATC code S02CA
ATC description CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-07-26
Estimated end date 2024-05-25
Actual end date
Shortage status Actual shortage
Updated date 2024-03-01
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 130 EAST DRIVE
BRAMPTON, ONTARIO
CANADA L6T 1C1
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v30 2023-03-10 English Compare
v29 2023-02-22 French Compare
v28 2023-02-22 English Compare
v27 2023-02-10 French Compare
v26 2023-02-10 English Compare
v25 2023-02-01 French Compare
v24 2023-02-01 English Compare
v23 2023-01-19 French Compare
v22 2023-01-19 English Compare
v21 2023-01-10 French Compare
v20 2023-01-10 English Compare
v19 2022-12-12 French Compare
v18 2022-12-12 English Compare
v17 2022-11-24 French Compare
v16 2022-11-24 English Compare
v15 2022-11-15 French Compare
v14 2022-11-15 English Compare
v13 2022-11-03 French Compare
v12 2022-11-03 English Compare
v11 2022-09-16 French Compare

Showing 21 to 40 of 50